These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18520520)

  • 1. Topical cyclosporin A in severe allergic conjunctivitis.
    Bellini LP; Bulla MC; Brum GS
    Cornea; 2008 Jun; 27(5):625; author reply 625. PubMed ID: 18520520
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops.
    Ozcan AA; Ersoz TR; Dulger E
    Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
    Akpek EK; Dart JK; Watson S; Christen W; Dursun D; Yoo S; O'Brien TP; Schein OD; Gottsch JD
    Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective review on the use of topical cyclosporin a 0.05% for paediatric allergic conjunctivitis in Hong Kong Chinese.
    Wu MM; Yau GS; Lee JW; Wong AL; Tam VT; Yuen CY
    ScientificWorldJournal; 2014; 2014():396987. PubMed ID: 25386595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of allergic conjunctivitis in children: the out-patients' department experience (allergic conjunctivitis in children: management and care).
    Napoli G; Allegri P; Musso C; Morchio AA; Callegarini L; Murialdo U; Tanca D; Marrè V
    Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):21-4. PubMed ID: 15745373
    [No Abstract]   [Full Text] [Related]  

  • 6. Topical cyclosporine inhibits mast cell-mediated conjunctivitis.
    Whitcup SM; Chan CC; Luyo DA; Bo P; Li Q
    Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2686-93. PubMed ID: 8977483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review: topical ophthalmic use of cyclosporin A.
    Utine CA; Stern M; Akpek EK
    Ocul Immunol Inflamm; 2010 Oct; 18(5):352-61. PubMed ID: 20735287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.
    Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical cyclosporin A in the management of vernal keratoconjunctivitis.
    Gupta V; Sahu PK
    Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of topical cyclosporine a 0.05%, cyclosporine a 2%, epinastine hydrochloride 0.05%, and prednisolone acetate 1% on allergic inflammation in an experimental allergic conjunctivitis model.
    Semsettin B; Sinan E; Nigar V
    Cornea; 2013 Nov; 32(11):1465-9. PubMed ID: 24055903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children.
    Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis.
    Wan KH; Chen LJ; Rong SS; Pang CP; Young AL
    Ophthalmology; 2013 Nov; 120(11):2197-203. PubMed ID: 23743438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment.
    Vichyanond P; Tantimongkolsuk C; Dumrongkigchaiporn P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P
    J Allergy Clin Immunol; 2004 Feb; 113(2):355-8. PubMed ID: 14767456
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic use of topical cyclosporine.
    Kaan G; Ozden O
    Ann Ophthalmol; 1993 May; 25(5):182-6. PubMed ID: 8517589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical cyclosporine prevents seasonal recurrences of vernal keratoconjunctivitis in a randomized, double-masked, controlled 2-year study.
    Lambiase A; Leonardi A; Sacchetti M; Deligianni V; Sposato S; Bonini S
    J Allergy Clin Immunol; 2011 Oct; 128(4):896-897.e9. PubMed ID: 21868078
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis.
    Kamis U; Ozturk BT; Ozkagnici A; Gunduz K
    Acta Ophthalmol Scand; 2006 Feb; 84(1):148-9. PubMed ID: 16445458
    [No Abstract]   [Full Text] [Related]  

  • 17. [0.05% cyclosporine a for treatment of chronic severe ocular surface disease].
    Nochez Y; Denoyer A; Pisella PJ
    Can J Ophthalmol; 2009 Aug; 44(4):406-11. PubMed ID: 19606161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical tacrolimus 0.03% monotherapy for vernal keratoconjunctivitis--case series.
    Tam PM; Young AL; Cheng LL; Lam PT
    Br J Ophthalmol; 2010 Oct; 94(10):1405-6. PubMed ID: 20558422
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of topical cyclosporin A 0.05% in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.
    Keklikci U; Soker SI; Sakalar YB; Unlu K; Ozekinci S; Tunik S
    Jpn J Ophthalmol; 2008; 52(5):357-362. PubMed ID: 18991035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated large limbal nodule as the presenting feature of vernal keratoconjunctivitis.
    Sugandhi P; Arora R
    J Pediatr Ophthalmol Strabismus; 2007; 44(1):49-50. PubMed ID: 17274337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.